Aussie tech startup acquired by Pfizer for $179 million after developing an app that can ‘hear’ COVID-19 Health Emma Elsworthy 28 September 2022 ASX-listed ResApp developed a smartphone application that studies showed could identify a COVID-19 infection from a person's cough.
Australian wing of Brisbane-born rapid test innovator Ellume enters administration Health David Adams 2 September 2022 Ellume has put its Australian wing into voluntary administration, 18 months after the company secured a $304 million US government contract to boost its COVID-19 test production capacity overseas.